Literature DB >> 9138968

Prognostic factors in cervical cancer.

H Pickel1, J Haas, M Lahousen.   

Abstract

The inadequacy of clinical methods has spurred efforts to develop objective, measurable and reproducible parameters for the spread and growth behaviour of cervical cancer. Morphological methods were applied first. They can be used only on the surgical specimen, but are accessible to biometry. The presented results are based on 479 surgical specimens obtained at radical abdominal hysterectomy for cervical cancers of different sizes. The specimens were processed as frontal giant sections with the cervix, the vaginal cuff and the parametria on both sides. The median follow-up time was 7-8 years. Statistical correlations were found between follow-up data, biometric morphologic criteria and survival. The statistical ranking of the significant prognostic factors produced the following order: lymph node metastases, size of lymph node metastases, tumour volume, parametrial involvement and vascular invasion.

Entities:  

Mesh:

Year:  1997        PMID: 9138968     DOI: 10.1016/s0301-2115(96)02637-1

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

1.  MicroRNA-335 represents an independent prognostic marker in cervical cancer.

Authors:  Changhe Wang; Tao Jiang
Journal:  Tumour Biol       Date:  2015-02-25

2.  Sentinel lymph node biopsy in the management of early-stage cervical carcinoma.

Authors:  John P Diaz; Mary L Gemignani; Neeta Pandit-Taskar; Kay J Park; Melissa P Murray; Dennis S Chi; Yukio Sonoda; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2011-01-08       Impact factor: 5.482

3.  URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer.

Authors:  Lan Zhang; He Huang; Longjuan Zhang; Teng Hou; Shu Wu; Qidan Huang; Libing Song; Jihong Liu
Journal:  BMC Cancer       Date:  2014-11-26       Impact factor: 4.430

4.  High expression of FUNDC1 predicts poor prognostic outcomes and is a promising target to improve chemoradiotherapy effects in patients with cervical cancer.

Authors:  Hailing Hou; Puchun Er; Jingjing Cheng; Xiuli Chen; Xiaofeng Ding; Yuwen Wang; Xi Chen; Zhiyong Yuan; Qingsong Pang; Ping Wang; Dong Qian
Journal:  Cancer Med       Date:  2017-07-18       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.